Lebrikizumab Pen Ease of Use in Participants With Atopic Dermatitis

Completed · Phase 3

Conditions studied: Atopic Dermatitis

In brief

The purpose of this study is to assess the ease of use of the lebrikizumab pen. Participants will use a practice pad to simulate administration of a dose. Participants will complete the modified Subcutaneous Administration Assessment Questionnaire (mSQAAQ) following the simulated injection. This study involves one study visit.

Key facts

Study ID

NCT06444165

Run by

Eli Lilly and Company

People needed

55

Starts

2024-06-04

Expected to finish

2024-06-10

Last updated by the study team

2025-07-29

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Self-report being diagnosed with atopic dermatitis (AD) by a physician and able to provide approximate diagnosis date.
• Autoinjector or Pen naïve [have not used an autoinjector or pen previously; permissible to have used a pre-filled syringe (PFS) or vial and syringe].
• Willing and able to attend an in-person interview session.
• Able to complete the protocol requirements.

You may not qualify if…

• Cognitive or physical difficulties that could interfere with ability to understand the training, perform the injection tasks, or complete the study questionnaires as judged by the investigator.
• Are currently enrolled or have participated in the last 3 months, in a clinical study involving an investigational product or any other type of medical research judged not to be scientifically or medically compatible with this study.
• Is a health care practitioner who is trained in giving injections.
• Currently pregnant.
• Known hypersensitivity to any component of lebrikizumab or its excipients.
• Treatment with a live (or live attenuated) vaccine within the past 12 weeks.
• Current or chronic infection with hepatitis B, hepatitis C, or human immunodeficiency virus (HIV) per participant self-report.

Where it is running

• Concentrics Research — Indianapolis, Indiana, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.